The store will not work correctly when cookies are disabled.
(E)-3-(4-hydroxy-3-methoxyphenyl)-1-(5-propylpyrazin-2-yl)prop-2-en-1-one
ID: ALA2288839
PubChem CID: 6474708
Max Phase: Preclinical
Molecular Formula: C17H18N2O3
Molecular Weight: 298.34
Molecule Type: Small molecule
Associated Items:
Names and Identifiers
Canonical SMILES: CCCc1cnc(C(=O)/C=C/c2ccc(O)c(OC)c2)cn1
Standard InChI: InChI=1S/C17H18N2O3/c1-3-4-13-10-19-14(11-18-13)15(20)7-5-12-6-8-16(21)17(9-12)22-2/h5-11,21H,3-4H2,1-2H3/b7-5+
Standard InChI Key: NBWVCOCKCXYOTG-FNORWQNLSA-N
Molfile:
RDKit 2D
22 23 0 0 0 0 0 0 0 0999 V2000
35.0718 -2.0471 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.0706 -2.8666 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.7787 -3.2756 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
36.4883 -2.8661 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
36.4855 -2.0435 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
35.7769 -1.6382 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
37.1917 -1.6322 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.9009 -2.0381 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
37.1886 -0.8150 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
38.6071 -1.6269 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
39.3163 -2.0328 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
39.3163 -2.8489 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
40.0247 -3.2547 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
40.7319 -2.8434 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
40.7261 -2.0220 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
40.0172 -1.6198 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
41.4308 -1.6082 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
42.1415 -2.0117 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
41.4416 -3.2484 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
34.3626 -3.2746 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.3619 -4.0918 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.6539 -4.4999 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 2 0
6 1 1 0
5 7 1 0
7 8 1 0
7 9 2 0
8 10 2 0
10 11 1 0
11 12 2 0
12 13 1 0
13 14 2 0
14 15 1 0
15 16 2 0
16 11 1 0
15 17 1 0
17 18 1 0
14 19 1 0
2 20 1 0
20 21 1 0
21 22 1 0
M END
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 298.34 | Molecular Weight (Monoisotopic): 298.1317 | AlogP: 3.04 | #Rotatable Bonds: 6 |
Polar Surface Area: 72.31 | Molecular Species: NEUTRAL | HBA: 5 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 5 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: 9.50 | CX Basic pKa: 0.02 | CX LogP: 2.66 | CX LogD: 2.65 |
Aromatic Rings: 2 | Heavy Atoms: 22 | QED Weighted: 0.66 | Np Likeness Score: 0.04 |
References
1. Opletalová V, Hartl J, Patel A, Palát K, Buchta V.. (2002) Ring substituted 3-phenyl-1-(2-pyrazinyl)-2-propen-1-ones as potential photosynthesis-inhibiting, antifungal and antimycobacterial agents., 57 (2): [PMID:11902656] [10.1016/s0014-827x(01)01187-9] |